A single nucleotide polymorphism in OPRM1(rs483481) and risk for heroin use disorder

Abstract

Opioid receptor mu1 (OPRM1) is the target of many opioid drugs, and it is known to have affinity toward both endogenous and exogenous opioids, opiate and opioid analgesic drugs. The present study was undertaken to explore association of single nucleotide polymorphisms (SNPs) in the OPRM1 gene with heroin use disorder. Ten OPRM1 polymorphisms were analyzed in 132 cases and 147 healthy controls. The SNP rs483481 showed significant allelic, genotypic and haplotypic association (Allelic: p-value = 0.003, OR = 1.75, CI = 1.21-2.55) (Genotypic: p-value = 0.003, OR = 1.72, CI = 1.08-2.75) with heroin use disorder. Allelic and genotypic association remained significant even after multiple testing corrections with 1000 permutations. A significant positive correlation between ‘Number of times drug abstained’ and ‘rs483481-AA genotype’ (p-value = 0.002; Pearson correlation = 0.265) was also observed. One-way ANOVA analysis demonstrated significant association of rs483481 with ‘number of times drug abstained’ (F = 4.86, p-value =0.009). ‘A’ allele and ‘AA’ genotype of marker rs483481 seem to confer protective effect while ‘G’ allele and ‘GG’ genotype potentiates risk for heroin use disorder. OPRM1 is found to be associated with heroin use disorder in the studied Manipuri cohort. The study suggests that individuals with G allele and GG genotypes at rs483481 could be more vulnerable to heroin dependence, and it could be taken into consideration in prevention and intervention programs.

Keywords:

• OPRM1
• heroin use disorder
• polymorphisms
• association
• drug

Acknowledgements

We are thankful to Social Awareness Service Organization and all participants in the study.

Author contributions

R.H., U.R. and K.M. conceived, designed and supervised the work; A.S.K. performed research work; B.C. assisted in research work; A.S.K. and R.H. analyzed data; A.S.K. and R.H. prepared the manuscript for publication. All the authors read and agreed to the manuscript.

Conflict of interest

None.

Additional information

Funding

Department of Biotechnology, Govt. of India.